1. Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?. (3rd August 2018) Authors: Perrella, A.; Izzi, A.; Punzi, R.; Adinolfi, E.; Sbreglia, C.; Bellopede, P.; Galeota Lanza, A.; Martucci, F.; Rinaldi, L. Journal: Scandinavian journal of gastroenterology Issue: Volume 53:Number 8(2018) Page Start: 1025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0228 Rituximab Monotherapy of Severe Hcv-Related Cryoglobulinemic Vasculitis for More than 2 Years: Follow-Up of A Randomized Controlled Multicentre Study. (10th June 2014) Authors: Quartuccio, L.; Zuliani, F.; Corazza, L.; Scaini, P.; Zani, R.; Lenzi, M.; Tavoni, A.; Sebastiani, M.; Baldovino, S.; Urraro, T.; Saccardo, F.; Sbreglia, C.; Mazzaro, C.; Pioltelli, P.; Fraticelli, P.; Filippini, D.; Gabrielli, A.; Perrella, O.; Scarpato, S.; Roccatello, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist. Issue 1 (December 2017) Authors: Nappi, A.; Perrella, A.; Bellopede, P.; Lanza, A.; Izzi, A.; Spatarella, M.; Sbreglia, C. Journal: Infectious agents and cancer Issue: Volume 12:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗